{"id":52755,"date":"2024-11-13T13:46:15","date_gmt":"2024-11-13T11:46:15","guid":{"rendered":"https:\/\/www.fyb.de\/athos-leads-34m-series-b-round-of-aignostics-ai\/"},"modified":"2024-11-13T13:46:15","modified_gmt":"2024-11-13T11:46:15","slug":"athos-leads-34m-series-b-round-of-aignostics-ai","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/","title":{"rendered":"ATHOS leads $34m Series B round of Aignostics (AI)"},"content":{"rendered":"<div class=\"page\" title=\"Page 1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>Munich \/ Berlin \u2014 Global arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) company Aigno\u00adstics has closed its latest $34 million Series B funding round. The round was led by ATHOS (Munich), with invest\u00adments from Mayo Clinic and growth funding from HTGF. Aigno\u00adstics also recei\u00adved support from exis\u00adting inves\u00adtors inclu\u00adding Welling\u00adton Part\u00adners, Boeh\u00adrin\u00adger Ingel\u00adheim Venture Fund, CARMA Fund and VC Fonds Tech\u00adno\u00adlo\u00adgie, mana\u00adged by IBB Ventures. To date, Aigno\u00adstics has raised over $55 million, demons\u00adt\u00adra\u00adting inves\u00adtor confi\u00addence in the company\u2019s unique AI models and well-defi\u00adned commer\u00adcial stra\u00adtegy. <strong>Aigno\u00adstics<\/strong> was foun\u00added in 2018 and emer\u00adged in 2020 as a spin-off from Charit\u00e9 and the Berlin Insti\u00adtute of Health. The AI company trans\u00adforms complex multi\u00admo\u00addal patho\u00adlo\u00adgi\u00adcal data into valuable insights. Follo\u00adwing the closing of the latest funding round, Aigno\u00adstics plans to deve\u00adlop new product offe\u00adrings for biophar\u00admaceu\u00adti\u00adcal custo\u00admers, drive growth in the US and deve\u00adlop advan\u00adced basic models for patho\u00adlogy in colla\u00adbo\u00adra\u00adtion with the Mayo Clinic. The new funding will streng\u00adthen Aigno\u00adstics\u2019 capa\u00adbi\u00adli\u00adties in target funding, trans\u00adna\u00adtio\u00adnal rese\u00adarch and compa\u00adn\u00adion diagno\u00adstics (CDx) and support various stra\u00adte\u00adgic initia\u00adti\u00adves. \u201c2024 was a pivo\u00adtal year for us, which included an important stra\u00adte\u00adgic colla\u00adbo\u00adra\u00adtion with Bayer and the launch of our first basic model, RudolfV,\u201d says <strong>Viktor Matyas, CEO and co-foun\u00adder of Aigno\u00adstics<\/strong>. \u201cWith RudolfV, we have gained the ability to rapidly deve\u00adlop cost-effec\u00adtive algo\u00adrithms that can be trans\u00adfer\u00adred to the real world. With this new round of funding, we are turning our most popu\u00adlar algo\u00adrithms into products that will help usher in an era of truly gene\u00adra\u00adlizable AI for compu\u00adta\u00adtio\u00adnal pathology.\u201d&nbsp;<\/p>\n<p><strong>About Aigno\u00adstics<\/strong><\/p>\n<p>Aigno\u00adstics is an arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) company that turns complex multi\u00admo\u00adda\u00adlity patho\u00adlogy data into trans\u00adfor\u00adma\u00adtive insights. By combi\u00adning proprie\u00adtary access to multi\u00admo\u00adda\u00adlity clini\u00adcal data, indus\u00adtry-leading tech\u00adno\u00adlo\u00adgies and rigo\u00adrous science, Aigno\u00adstics deve\u00adlops world-class products and services for the next gene\u00adra\u00adtion of precis\u00adion medi\u00adcine. Through colla\u00adbo\u00adra\u00adtion with its biopharma part\u00adners, Aigno\u00adstics supports drug disco\u00advery, trans\u00adla\u00adtio\u00adnal rese\u00adarch, clini\u00adcal trials and CDx deve\u00adlo\u00adp\u00adment. Foun\u00added in 2018, Aigno\u00adstics is a spin-off of Charit\u00e9 Berlin, one of the largest and most renow\u00adned univer\u00adsity hospi\u00adtals in the world. Aigno\u00adstics is funded by leading inves\u00adtors and has offices in Berlin and New York. Further infor\u00adma\u00adtion at aignostics.com.     <\/p>\n<p><strong>About ATHOS<\/strong><\/p>\n<p>ATHOS is a single-family office (Str\u00fcng\u00admann Group) that supports entre\u00adpre\u00adneurs to posi\u00adtively impact health and well-being. The company is a long-term majo\u00adrity inves\u00adtor in BioNTech.&nbsp;<\/p>\n<p><strong>Advi\u00adsor Aigno\u00adstics: YPOG<\/strong><\/p>\n<p>Dr. Martin Scha\u00adper (Lead, Corporate\/Transactions), Part\u00adner, Berlin Dr. Jonas von Kalben (Tran\u00adsac\u00adtions), Senior Asso\u00adciate, Berlin<br>\nAnja Schind\u00adler (Tran\u00adsac\u00adtions), Senior Asso\u00adciate, Berlin<br>\nBene\u00addikt Kreu\u00adder (Tran\u00adsac\u00adtions), Senior Asso\u00adciate, Berlin<br>\nDr. Jacob Schrei\u00adber (Tran\u00adsac\u00adtions), Senior Asso\u00adciate, Munich<\/p>\n<p><strong>About YPOG<\/strong><\/p>\n<p>YPOG is a law firm specia\u00adli\u00adzing in tax and commer\u00adcial law, active in the core areas of funds, tax, banking + finance and tran\u00adsac\u00adtions. The YPOG team advi\u00adses a wide variety of clients. These include emer\u00adging tech\u00adno\u00adlogy compa\u00adnies and family-run medium-sized enter\u00adpri\u00adses as well as corpo\u00adra\u00adti\u00adons and private equity\/venture capi\u00adtal funds. YPOG is one of the leading addres\u00adses for venture capi\u00adtal, private equity and fund struc\u00adtu\u00adring in Germany. The firm and its part\u00adners are ranked natio\u00adnally and inter\u00adna\u00adtio\u00adnally by JUVE, Best Lawy\u00aders, Legal 500, Focus, Cham\u00adbers and Part\u00adners and Leaders League. Today, YPOG employs more than 150 expe\u00adri\u00aden\u00adced lawy\u00aders, tax consul\u00adtants, tax specia\u00adlists and a notary in four offices in Berlin, Hamburg, Colo\u00adgne and Munich. www.ypog.law<\/p>\n<\/div>\n<\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Munich \/ Berlin \u2014 Global arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) company Aigno\u00adstics has closed its latest $34 million Series B funding round. The round was led by ATHOS (Munich), with invest\u00adments from Mayo Clinic and growth funding from HTGF. Aigno\u00adstics also recei\u00adved support from exis\u00adting inves\u00adtors inclu\u00adding Welling\u00adton Part\u00adners, Boeh\u00adrin\u00adger Ingel\u00adheim Venture Fund, CARMA Fund and&nbsp;VC&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":52753,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1369,1373],"tags":[],"class_list":["post-52755","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-investors","category-venture-capital-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>ATHOS leads $34m Series B round of Aignostics (AI) - FYB Financial Yearbook<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATHOS leads $34m Series B round of Aignostics (AI) - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Munich \/ Berlin \u2014 Global arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) company Aigno\u00adstics has closed its latest $34 million Series B funding round. The round was led by ATHOS (Munich), with invest\u00adments from Mayo Clinic and growth funding from HTGF. Aigno\u00adstics also recei\u00adved support from exis\u00adting inves\u00adtors inclu\u00adding Welling\u00adton Part\u00adners, Boeh\u00adrin\u00adger Ingel\u00adheim Venture Fund, CARMA Fund and VC [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-13T11:46:15+00:00\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"ATHOS leads $34m Series B round of Aignostics (AI)\",\"datePublished\":\"2024-11-13T11:46:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/\"},\"wordCount\":540,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/aignostics-gruenderteam-aignostics.avif\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Investors\",\"Venture Capital\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/\",\"url\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/\",\"name\":\"ATHOS leads $34m Series B round of Aignostics (AI) - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/aignostics-gruenderteam-aignostics.avif\",\"datePublished\":\"2024-11-13T11:46:15+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/aignostics-gruenderteam-aignostics.avif\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/aignostics-gruenderteam-aignostics.avif\",\"width\":1600,\"height\":1067,\"caption\":\"Die vier Aignostics-Gr\u00fcnder: (v.l.) Frederik Klauschen, Maximilian Alber, Klaus-Robert M\u00fcller und Viktor Matyas. \u00a9 Aignostics\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATHOS leads $34m Series B round of Aignostics (AI)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATHOS leads $34m Series B round of Aignostics (AI) - FYB Financial Yearbook","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/","og_locale":"en_US","og_type":"article","og_title":"ATHOS leads $34m Series B round of Aignostics (AI) - FYB Financial Yearbook","og_description":"Munich \/ Berlin \u2014 Global arti\u00adfi\u00adcial intel\u00adli\u00adgence (AI) company Aigno\u00adstics has closed its latest $34 million Series B funding round. The round was led by ATHOS (Munich), with invest\u00adments from Mayo Clinic and growth funding from HTGF. Aigno\u00adstics also recei\u00adved support from exis\u00adting inves\u00adtors inclu\u00adding Welling\u00adton Part\u00adners, Boeh\u00adrin\u00adger Ingel\u00adheim Venture Fund, CARMA Fund and VC [&hellip;]","og_url":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2024-11-13T11:46:15+00:00","author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"ATHOS leads $34m Series B round of Aignostics (AI)","datePublished":"2024-11-13T11:46:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/"},"wordCount":540,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/aignostics-gruenderteam-aignostics.avif","articleSection":["General","Featured","News","Lawyers\/Tax-advisors\/Auditors","Investors","Venture Capital"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/","url":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/","name":"ATHOS leads $34m Series B round of Aignostics (AI) - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/aignostics-gruenderteam-aignostics.avif","datePublished":"2024-11-13T11:46:15+00:00","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/aignostics-gruenderteam-aignostics.avif","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/11\/aignostics-gruenderteam-aignostics.avif","width":1600,"height":1067,"caption":"Die vier Aignostics-Gr\u00fcnder: (v.l.) Frederik Klauschen, Maximilian Alber, Klaus-Robert M\u00fcller und Viktor Matyas. \u00a9 Aignostics"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/athos-leads-34m-series-b-round-of-aignostics-ai\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"ATHOS leads $34m Series B round of Aignostics (AI)"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52755","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=52755"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/52755\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/52753"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=52755"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=52755"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=52755"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}